Ahmed Bouzidi is the Managing Director Europe & VP International BD at Trinomab Biotech, and also the Acting Vice President of Biotech at ProductLife Group. Previously, Ahmed served as the Chief Executive Officer at Immunal Therapeutics Ltd and held various leadership roles in biopharmaceutical companies such as European Biopharmaceutical Enterprises, Vaxeal Holding SA, Vaxeal Therapeutics inc., Vaccines Europe, Biophysiomics SA, and SEDAC-Therapeutics SA. Ahmed Bouzidi holds a PhD in Biology from the University of New Hampshire.
March, 2021 - present